The Max Pulse device performs two functions.
Arterial Testing Function: The 1 minute arterial test will detect:
- Early stage arterial hardening, so early that the condition is reversible giving patients an early wake up call and a chance to act.
- Early/mid stage heart weakening, the beginning of congestive heart failure, often when the patient is unaware, but is showing symptoms such as edema but has disregarded them.
- Late stage arterial hardening, sufficiently advanced that it is not easily reversible and may even require surgical intervention (such as stenting). This can be life saving. Our equipment will detect advanced arterial hardening before BP and other markers are definite.
This is aimed at Primary care where it is impractical to do carotid dopplers or other advanced screenings on a high volume of patients. The machine offers incredible value to patients as they can be warned when their arterial health starts to decline or rescued when decline has already occurred.
Value to Medical Practice: There is a billing component to the machine. While our company does not recommend billing codes, the manufacturer has stated that 93922 might be appropriate and while reimbursement varies greatly state-to-state, we have had positive feedback from a number of doctors regarding this.
The secondary value is that the machine can show patients the value of various therapies being offered. For example you can test after the use of an innovative therapy and you will often see small bumps in the more sensitive markers that the report generates. You can validate your other treatments using the Max Pulse.
Heart Rate Variability Testing: The 3 minute test will show:
If the patient is stressed or fatigued
If the patient is reaching the end of their ability to withstand the stress or fatigue they are under (Stress Resistance).
If the stress or fatigue is mostly physical or mostly mental.
The HRV test is unique and very sensitive.
Peer Reviewed Scientific Studies
There are many studies of this technology all the way from PLOS one to the Journal of Hypertension. But this article covers the technology in great detail going step by step through each aspect of the technology. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3394104/. The articles gives many references for each steps of the development of this technology. To get the most applicable part of the article, scroll all the way down to C. Second Derivative Photoplethysmogram. Our equipment uses the Second Derivative (APG). There are a number of additional references that can be searched there. We have a lot of them on our website – https://longlifecardio.com/ scientific-research/.
HRV has been extensively studied and connected to mortality in a number of studies. We have a number of studies that are appropiate – just contact us to ask for this information.